This article further investigates the determinants of health expenditures by using aggregate data. Specifically, a panel data analysis of 25 OECD countries reveals that under several model specifications, the proxy for population ageing has no effect on health costs in accordance with recent findings. In contrast to this well-known result, an additional estimation conducted to check robustness revealed that the ageing variable becomes positive and significant. The significant effect may provide a new signal for a determinant of health expenditures. This result suggests that ageing is an important factor that cannot be ignored when considering variations in health expenditures.
Introduction
This article further investigates the determinants of health expenditures, which have been widely examined in econometric analyses of health care services. For this empirical study, OECD Health Data are used to construct a cross-country panel dataset and examined several issues by standard analytical methods.
In previous studies on the determinants of per capita health expenditures, the age structure of a country's population (i.e., ageing of the population) has been considered an influential factor in increased expenditures in the health care sector, along with other important factors Recently, in addition to the importance of the proximity of death for health cost determinants, as highlighted by Zweifel et al. (1999) , Dormont et al. (2010) reevaluate the importance of the ageing factor according to the graphical analysis by Yang et al. (2003) . Against this background, a reexamination of this issue is now useful.
To reexamine the impacts of population ageing given our analytical aim described above, we employ samples targeting periods of time in which societal ageing progressed rapidly.
Although our primary goal is to examine the relationship between ageing and health costs, we also investigate the effects of other important variables including income level and proxies for the system of medical service. This approach is the notable feature of the present study compared with the literature, where focus is placed upon long-run economic relationships among some major variables. Baltagi and Moscone (2010) provide one such example: they examine the non-stationarity and cointegration properties between per capita health care expenditure and per capita GDP. Furthermore, it is interesting to examine whether differences in estimation methods and the selection of explanatory variables affect the impact of population ageing on health expenditures. As shown in Baltagi and Moscone (2010) , estimates for ageing variables are sensitive to estimation methods. Therefore, we address such problems by using standard panel data analysis with a unified test procedure.
The rest of the article is organized as follows. Section 2 explains the econometric model and data employed in this study. Section 3 presents the estimation results. Lastly, Section 4 presents the study's conclusions.
Model specification and data
We developed a standard panel regression approach, which is a familiar one in the study of the determinants of health care expenditures. As the benchmark panel regression model, the individual-specific effects model (the fixed effects (FE) or random effects (RE) model) is specified as follows:
where i = 1, ..., N denotes a cross-section index of countries, and t = 1, ..., T denotes the time-series index. 4 The dependent variable in (1) is the logarithm of real per capita health expenditures (HE ). Real GDP per capita (GDP ) and the ratio of the population aged 65 and over to the total population (POP65 ) are two fundamental variables in our regression analysis.
The vector x corresponds to a set of explanatory (control) variables explained below. ϵ is the error term. Note that all variables in (1), including the variable on the left hand side but not the dummy variable, are expressed as natural logarithms. This implies that the functional form be a log-log specification, and thus we can interpret the estimated coefficients α, β, and γ as standard elasticities. * * * * * Table 1 here * * * * *
Here the unbalanced panel dataset includes 11 variables for 25 OECD countries over the period 1985-2006. 5 The variables are listed in Table 1 . In the literature, the fundamental variable GDP is widely used for studying health expenditure determinants (Gerdtham and Jönsson, 2000) . The highlight of the present analysis is the behaviour of the sign and the significance of the estimated coefficient for POP65. Namely, when POP65 has a positive value, population ageing is a potential source of rising health costs. We also consider POP14, the ratio of the population aged 0-14 to the total population, as the variable for the population age structure. An increase in the share of young people within the population appears to reduce health costs (Mosca, 2007) .
As other control variables, the following three variables reflecting the supply side and institutional characteristics of health care are examined: ABED, PUBE, and DCOVER.
ABED is acute-care bed density, an increase in which is associated with higher health expenditures. Following Baltagi and Moscone (2010), we also consider the intensity of public engagement in overall health expenditures. This is captured by the variable PUBE, corresponding to the share of public health expenditures out of total health expenditures.
We assume that a higher share will increase health costs. In association with PUBE, an institutional dummy variable DCOVER is included in the regression equation, and takes the value 1 if the relevant country has an above average value for health care coverage (% of total population) each year, or 0 otherwise. 6 This variable accounts for the level of improvement in publicly provided health care systems.
In addition to the abovementioned variables directly related to health, the following socioeconomic variables are also included in the regression analysis: FLABOUR, POPD, and Table 3 shows benchmark estimation results from variations of (1). Columns (1a)- (1c) show a set of standard panel estimations: pooled, FE, and RE. As is well known, by practicing a series of unified tests we can select a suitable model. The choice between the pooled and enhances household income levels. As noted before, the advancement of urbanization (captured by POPD in this study) has a complex impact on health expenditures. Because the coefficient for POPD is positive but insignificant, this result tells us that urbanization has no relevance to national health expenditures. 10 As expected, the rate of unemployment (UNEMPLOY ) has a significant influence on health expenditures. The estimated coefficient is positive-a 1% increase in the unemployment rate leads to health costs rising by about 0.05% points-showing that addressing employment issues in the macroeconomy is related to health care issues, and thus raises some important implications.
Estimation results
Finally, we find that the time variable TIME is positive and significant at the 1% level. This implies that the sample countries transform gradually into a high-cost structure, probably due to technological change in the medical care and pharmaceutical sectors.
Robustness of the benchmark results
In this subsection, we examine the robustness of the benchmark estimations. Comparing the correlation coefficients among the explanatory variables, we find that our essential variable POP65 is highly correlated with POP14. 11 As is well known, high correlation among the regressors may produce a multicollinearity problem. In light of this, reestimating (1b) and (1c) without POP14 yields the results of columns (2a) and (2b) in Table 4 . 12 Since the three specification tests put forward the FE model, let us further consider the results for (2a). The estimated coefficients for fundamental variables GDP and POP65 remain much the same as before. We can therefore verify that population ageing barely affects health expenditures. Although the estimates of the other variables are similar to those of (1b), changes in the following three points should be noted. First, the significance level of the estimate for FLABOUR becomes higher; second, technological change in the health sector (captured by TIME ) still has high explanatory power; and third, the goodness of fit (R 2 ) is better.
signal of a critical transition in the health environment. Moreover, according to the insight by Dormont et al. (2010) on the basis of Yang et al. (2003) , although death proximity supported by microeconometric studies is surely important as a determinant of health expenditures, the ageing effect still cannot be ignored. Our findings possibly relate to the insight gleaned from the regression analysis using cross-country panel data. However, some problems with the overall result of this estimation remain. We must bear in mind that the relatively short-run estimation of (5) has less credibility in comparison with our previous estimates. Specifically, the results of these estimates differ markedly, except for the two fundamental variables and the proxy variable for technological change (TIME ). 14 In addition, the substantial deterioration in R 2 exemplifies the problem. Therefore, the result for POP65 in the last estimation should be treated provisional, but might be a new signal for ageing effects on health costs.
Conclusions
Using a panel of 25 OECD countries over the periods 1985-2006, 1990-2006, and 1997-2006 , this study comprehensively examined the determinants of health expenditures.
We focused in particular on the estimated coefficient for the ratio of the population aged 65 and over (POP65 ) as a proxy for population ageing under various model specifications with many control variables. There were three main results obtained from this study. First, the benchmark estimation of (1b) through a set of standard tests in a panel study found insignificant ageing effects. Second, this result was clearly confirmed in the estimations dealing with possible econometric problems. Our result is therefore robust and consistent with recent empirical evidence in the literature. Third, in the 1997-2006 estimation conducted to check robustness, we found significant ageing effects contrary to our previous regressions. This unique result calls for reconsidering the stylized relationships between population ageing and health care expenditures, and represents a possible new signal. Also indicated is the essential need to continue observing the impacts of a country's age structure on health costs.
Other important findings are that (i) the estimated income elasticities obtained in this study are smaller than unity, implying that health care service is a necessary not luxury good; (ii) along with GDP, FLABOUR, POPE, UNEMPLOY, and TIME also appeared to affect health expenditures in the robust long-term sample of 1985-2006 and (iii) among these variables in particular, TIME exhibited high significance in all estimations as a proxy for 14 The coefficient for TIME exhibits a high significance with the expected sign. This likely indicates rapid year-to-year progress in medical technologies, and deserves careful attention.
technological change in the health sector; this has been frequently mentioned, including by Newhouse (1992) , because taking account of technological change is crucial for investigating the key factors related to rising health costs.
The subject of this paper warrants further study in greater detail. Under a similar framework, an additional investigation with a longer sample period is needed to determine whether the stylized facts advocated in the microeconometric literature (i.e., insignificant ageing effects) and the new signal captured by the present analysis (i.e., significant ageing effects) is probable. Such investigation is needed in order to formulate better health care
policies. In addition, to resolve the potential endogeneity problem, we should employ instrumental variables estimation. Such an approach will make it possible to conduct an analysis with greater credibility. Constant term is included in each regression. Sample size is 25. Standard errors are shown in parentheses.
***, ** denote significance at 1 and 5% levels, respectively.
Table 5
Estimation results (3).
(4) Constant term is included in each regression. Sample size is 25. Standard errors are shown in parentheses.
